Current Committee Members (2020/2021)
Chairperson: John Michael Morris (formerly HPRA)
Michael obtained a degree in Pharmacy and PhD from the University of Manchester and worked briefly in industry in the UK. He then worked as a QA pharmacist in a number of hospital based manufacturing plants in the UK over the next 10 years. In 1987, he moved to Ireland to work for NDAB/IMB/HPRA and became Director Scientific Affairs at the Health Products Regulatory Authority (HPRA) of Ireland in 2004 until he retired at the end of 2015. Michael was formerly Pharmaceutical Director, IMB, responsible for the assessment of quality data (CMC data) and before that Senior Pharmacist at the Irish National Drugs Advisory Board. Dr. Morris was the EU member of the ICH Q6A Expert Working Group, and subsequently became EU topic leader and then Chair of ICH Q4B -pharmacopoeial harmonisation. In 2004 he was elected to the position of Chairman of the European Pharmacopoeia Commission until 2007 and he remained a member of the Ph. Eur.Commission until 2016. He is Chair of Ph. Eur. Working Party PAT and a member of Group 12, pharmaceutical dose forms. He has also served on a number of committees of PSI, Steering Committee of IIOP and the dissolution testing focus group of FIP. He has also been very active in the Ireland chapter of PDA since its inception in 2006 and has just recently stepped down after two years as President of that organization.
Treasurer: Peter Twomey (HPRA)
Peter joined the Health Products Regulatory Authority (HPRA) in July 2017 as Good Clinical Practice & Pharmacovigilance Inspector. Prior to joining the HPRA, he held various positions including the position of pharmacovigilance inspector with the MHRA (the UK medicines regulator) and qualified person for pharmacovigilance (QPPV) and pharmacovigilance manager in industry. He holds a Master of Pharmacy degree from RCSI.
Secretary: Sarah Condon (HPRA)
Gwynne Morley (IQVIA)
Gwynne is the General Manager in IQVIA (formerly IMS Health & Quintiles). She previously held the positions of Commercial Manager (IQVIA), Director of Heart & Vascular, Diabetes & Emergency Department at the Mater Private and Managing Director at Uniphar Retail Services division. She has extensive experience and knowledge of the pharmaceutical industry, from the manufacturer to the patient. Previously she worked for United Drug Group (UDG) Healthcare for 13 years where she was a member of the Senior Executive team. During her tenure with UDG, she held a number of senior roles namely in pre-wholesale, consumer, homecare and quality. Prior to joining UDG, she held management positions within the Crowley Retail Pharmacy Chain and held a multifunctional role within the medical department of Zeneca Pharma, Ireland. She is a graduate of TCD. Gwynne is the former PIER Chairperson (2014-2017).
Maura Kinahan (Pfizer)
Maura is Hospital Medical Lead in Pfizer Healthcare Ireland. She has spent most of her career to-date in various roles in the pharmaceutical industry (Pharmaceutical Development, Regulatory Affairs, Supply Chain, Commercial, Medical Affairs) with Élan, Bristol-Myers Squibb & Pfizer. In 2014/15, she participated in the BioInnovate Fellowship programme, a specialist medical device innovation training programme based in NUI Galway. She holds a pharmacy degree from the University of Strathclyde, Glasgow and PhD from the University of Manchester. She is a founding member of PIER.
Peter Patrick O'Donnell (Aspen)
Peter is currently working as a PV (Pharmacovigilance) Scientist for Aspen Pharmacare. He studied Pharmacy at RCSI for both his BSc (Pharm) and MPharm, graduating in 2015. During his MPharm he was a Research Assistant in the Tissue Engineering Research Group (TERG). After his MPharm Peter returned to the TERG as a Deputy Project Manager of an in-vivo trial for a commercialisation project after which he then joined the HPRA as a Scientific Officer for Pharmacovigilance within the Human Products Monitoring (HPM) department. Peter has also worked as a community pharmacist with Lloyds Pharmacy group as well as locum agencies.
Jane O'Sullivan (Pfizer)
Jane graduated from the Royal College of Surgeons in Ireland with a Master of Pharmacy in 2016. She completed an internship in both Lloyds Pharmacy, Dublin and the Pharmaceutical Assessment Department of the Health Products Regulatory Authority (HPRA), who are responsible for the assessment of quality/CMC data of medicinal products. Following the HPRA, she moved to London to work in the European Medicines Agency (EMA) in the Specialised Scientific Disciplines Department. She was based in the Clinical Pharmacology and Non-Clinical Office and primarily worked with the assessment of new centralised applications for these scientific disciplines. In mid 2018, Jane returned to Ireland and currently works in Pfizer in the Global Regulatory Affairs team for biologicals.
Blánaid O'Connell (AbbVie)
Blánaid is currently Market Access Manager at Abbvie since January 2019. She was previously an MSL (Onc/Haem) at Merck Serono after spending the bulk of her career as a hospital pharmacist working in both the private and public sectors and in the NHS and HSE. She held varying roles such as Chief Pharmacist at the Galway Clinic Private Hospital and Clinical Pharmacist in Oncology and the Mental Health Services before taking up the position as Chief Pharmacist at Mayo University Hospital which she held for six years before taking the leap into the Pharmaceutical industry. She hails from three generations of Pharmacists and graduated with a BSc Pharmacy from the Robert Gordon University,Aberdeen and has a PG in Psychiatric Therapeutics from Aston University, Birmingham.
Joey O'Shea (UCC)